prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. B. RIGHT BREAST. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. B. RIGHT BREAST. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. Received fresh labeled with the patient's name and designated "sentinel LN #1 right axilla" is a 2.2 x 1.5. x 0.6 cm lymph node. Touch preps are prepared. Lymph node and fibroadipose tissue are entirely. submitted. A1: one lymph node. A2: fibroadipose tissue with additional possible lymph nodes. B. RIGHT BREAST. Received fresh labeled with the patient's name and "right breast" is an oriented (stitch in axillary tail),. 1544g, 35.5 x 26 x 6.2 cm mastectomy with 24 x 14 cm skin ellipse and 1.1 cm everted nipple. Ink code: anterior superior-blue, anterior inferior-orange, posterior-black. The specimen is serially sectioned into. 16 slices from medial to lateral with nipple in slice 5 revealing a 4 x 2.2 x 0.7 cm tan, firm, spiculated. mass, in the upper outer quadrant, slices 6-8, 4.4 cm from the deep margin. The axillary tail is sectioned. to reveal multiple pink-tan lymph nodes. Tissue is procured. Representatively submitted: B1-B2: slice 5, nipple. B3: slice 7, mass. B4: slice 7, mass (adjacent tissue to section in B3). B5: slice 8, mass with skin. B6: slice 7, deep margin overlying mass. B7: slice 8, anterior inferior margin adjacent to mass. B8: slice 9, upper outer quadrant with deep margin. B9: slice 9, lower outer quadrant. B10: slice 4, upper inner quadrant. B11: slice 5, central. B12: slice 2, lower inner quadrant. B13: one lymph node, bisected. B14: one lymph node. B15: six possible lymph nodes. B16: four possible lymph nodes. B17: four possible lymph nodes. B18: one lymph node, bisected. B19: four possible lymph nodes. DIAGNOSIS: A. SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY: TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). B. BREAST, RIGHT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 1. - 2 CM IN SIZE. - MARGINS, FREE OF CARCINOMA. - DUCTAL CARCINOMA IN SITU (DCIS), CRIBRIFORM TYPE,. NUCLEAR GRADE 1, WITH MICROCALCIFICATIONS. - NIPPLE, NO TUMOR SEEN. - NINE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/9). SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2cm. Tumor Site: Upper outer quadrant. Margins: Negative. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 1. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Axillary dissection. Lymph node status: Negative 0/11. Non-neoplastic areas: radial scars. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 15%. DCIS Type: Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. Location of CA++: DCIS. Benign epithelium. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 1c N 0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: mammogram 8/13-nodular parenchymal enhancement of right breast. PRE-OPERATIVE DIAGNOSIS: Invasive ductal cancer right breast. INTRA-OPERATIVE CONSULTATION DIAGNOSIS: TPA: Sentinel node #1, right axilla - Negative for carcinoma. Microscopic/Diagnostic Dictation: M.D. Final Review:, M.D., Pathologist. Final Review:, M.D., Pathologist,. Final:, M.D., Pathologist,.

expanded version (tokens=1500) : 
 The breast pathology report lists the following information:

1. Histological Classification:
- Invasive ductal carcinoma, Nottingham Grade 1.
- Ductal carcinoma in situ (DCIS), cribriform type, nuclear grade 1.

2. Subtype: LumA

3. Description of any necrosis: Absent.

4. Tumor infiltrating lymphocytes: Not mentioned.

5. Histological grade: 
- Invasive ductal carcinoma: Tubular score 2, Nuclear grade 2, Mitotic score 1, Modified Scarff Bloom Richardson grade 1.
- DCIS: Nuclear grade 1.

6. Lymphovascular invasion: None identified.

7. Calcification: Microcalcifications seen with DCIS.

8. Receptor status:
- ER: Positive.
- PR: Positive.
- HER2: Negative by FISH.

9. IHC and other ancillary testing results: None mentioned, except for HER2 testing by FISH which was negative.

10. Margins: Free of carcinoma.

11. Surgical specimens:
- A. Sentinel lymph node #1 right axilla: Two lymph nodes, negative for carcinoma (0/2).
- B. Right breast mastectomy: 9 lymph nodes, negative for carcinoma (0/9).

12. Clinical history: Mammogram showed nodular parenchymal enhancement of the right breast.

13. Pre-operative diagnosis: Invasive ductal cancer right breast.

14. In

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1649) : 
 The breast pathology report reveals invasive ductal carcinoma (Nottingham Grade 1) with DCIS (Cribriform type, Nuclear grade 1), calcifications and a clear margin. ER/PR positive, HER2 negative. LumA subtype. No necrosis, tumor infiltrating lymphocytes or lymphovascular invasion were identified with negative sentinel and axillary lymph nodes. The nodular parenchymal enhancement was evident on mammogram. Pre-operative diagnosis confirmed as invasive ductal cancer right breast.

